Thiogenesis Therapeutics Corp Sustainability Reports
Thiogenesis Therapeutics Corp focuses on developing novel therapeutics targeting oxidative stress and mitochondrial dysfunction for the treatment of rare diseases.
Sector: Health Care
Country: Canada
Exchange: TSX Venture Exchange
ISIN: CA88410L1022
1 reports from 2024 to 2024
Company Profile
Thiogenesis Therapeutics Corp
Thiogenesis Therapeutics Corp focuses on developing novel therapeutics targeting oxidative stress and mitochondrial dysfunction for the treatment of rare diseases.
Reports